The relationship between PERK and PSAT1-mediated serine biosynthesis opens up possibilities for reprogramming or editing M2 macrophages, which may benefit the treatment of cancer or other inflammatory diseases (Raines et al., 2022). The gene discussed is PSAT1; the disease is cancer.